CVE-2012-0987

Public Exploit

Description

Directory traversal vulnerability in edituser.php in ImpressCMS 1.2.x before 1.2.7 Final and 1.3.x before 1.3.1 Final allows remote authenticated users to include and execute arbitrary local files via a .. (dot dot) in the icmsConfigPlugins[sanitizer_plugins][] parameter.

Category

6.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 2.74% Top 15%
Vendor Advisory impresscms.org Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/72146 vdb entry
http://www.securityfocus.com/bid/51268 vdb entry
https://www.htbridge.com/advisory/HTB23064
http://community.impresscms.org/modules/smartsection/item.php?itemid=579 patch vendor advisory
http://www.osvdb.org/78143 vdb entry exploit
http://secunia.com/advisories/47448 third party advisory vendor advisory
http://archives.neohapsis.com/archives/bugtraq/2012-01/0022.html mailing list exploit

Frequently Asked Questions

What is the severity of CVE-2012-0987?
CVE-2012-0987 has been scored as a medium severity vulnerability.
How to fix CVE-2012-0987?
To fix CVE-2012-0987, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-0987 being actively exploited in the wild?
It is possible that CVE-2012-0987 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.